Skip to main content
. 2022 Jul 16;15(7):876. doi: 10.3390/ph15070876

Figure 7.

Figure 7

Integrated CS-I/J@CM NPs remodel the tumor immunosuppressive microenvironment to improve glioblastoma immunotherapy [63].